Professional
Added to YB: 2025-02-24
Pitch date: 2024-12-31
CDNA [bullish]
CareDx, Inc
-8.04%
current return
Author Info
No bio for this author
Company Info
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
Market Cap
$819.6M
Pitch Price
$21.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
-88.86
P/E
13.12
EV/Sales
1.82
Sector
Biotechnology
Category
growth
Alger Small Cap Focus Fund Portfolio Holding: CareDx, Inc
CDNA: Q3 revenue +23% YoY but missed expectations. 2024 guidance raised, 2025 growth target high teens. Aiming for 15% CAGR by 2027. Expanding sales, marketing & billing teams. Specialty lab for transplant diagnostics, offering pre/post-transplant care solutions. Stock underperformed on Q3 miss.
Read full article (1 min)